NL-OMON23726招募中不适用
Five year single blind, Phase III effectiveness randomised actively controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Steroids Treatment versus Steroids plus Cyclosporine Treatment versus Steroids plus Methotrexate Treatment.
no commercial sponsoring. International organisation is PRINTO (pediatric rheumatology International trials organisation0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Newly onset juvenile dermatomyositis;
- •2. Patients aged <18 years;
排除标准
- •1. Neutropenia;
- •2. Failure to comply;
研究者
相似试验
进行中（未招募）
1 期
Five year single-blind, phase III effectiveness randomised actively controlled clinical trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine A versus prednisone plus methotrexateJuvenile Dermatomyositis at onsetEUCTR2005-003956-37-DKIstituto Giannina Gaslini132
进行中（未招募）
1 期
Five year single-blind, phase III effectiveness randomised actively controlled clinical trial in new onset juvenile systemic lupus erythematosus nephritis: oral cyclophosphamide versus high dose intravenous cyclophosphamide versus intermediate dose intravenous cyclophosphamide - PRINTO JSLE TrialEUCTR2005-003957-28-BEniversity Hospital Gent216
进行中（未招募）
不适用
Five year single-blind, phase III effectiveness randomised actively controlled clinical trial in new onset juvenile dermatomyositis:prednisone versus prednisone plus cyclosporine A versus prednisone plus mehotrexateJuvenile Dermatomyositis at onsetEUCTR2005-003956-37-NLIstituto Giannina Gaslini160
进行中（未招募）
不适用
Five year single blind, phase III effectiveness randomised actively controlled clinical trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine A versus prednisone plus methotrexateJuvenile Dermatomyositis at onsetEUCTR2005-003956-37-SEIstituto Giannina Gaslini132
进行中（未招募）
不适用
Five year single blind, phase III effectiveness randomised actively controlled clinical trial in new onset juvenile dermatomyositis: prednisolone versus prednisone plus cyclosporine A versus prednisone plus methotrexateJuvenile Dermatomyositis at onsetEUCTR2005-003956-37-GBIstituto Giannina Gaslini132